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Raised intracranial pressure (ICP) and low cerebral blood flow (CBF) are associated with ischae-
mia and poor outcome after brain injury. Therefore, many management protocols target these
parameters. This overview summarizes the technical aspects of ICP and CBF monitoring, and their
role in the clinical management of brain-injured patients. Furthermore, some applications of these
methods in current research are highlighted. ICP is typically measured using probes that are
inserted into one of the lateral ventricles or the brain parenchyma. Therapeutic measures used to
control ICP have relevant side-effects and continuous monitoring is essential to guide such
therapies. ICP is also required to calculate cerebral perfusion pressure which is one of the
most important therapeutic targets in brain-injured patients. Several bedside CBF monitoring
devices are available. However, most do not measure CBF but rather a parameter that is thought
to be proportional to CBF. Frequently used methods include transcranial Doppler which mea-
sures blood flow velocity and may be helpful for the diagnosis and monitoring of cerebral
vasospasm after subarachnoid haemorrhage or jugular bulb oximetry which gives information
on adequacy of CBF in relation to the metabolic demand of the brain. However, there is no clear
evidence that incorporating data from CBF monitors into our management strategies improves
outcome in brain-injured patients.
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Intracranial pressure
What are we monitoring and how does it work
The fundamental principles of raised intracranial pressure
(ICP) are condensed in the doctrine credited to Professors
Monro (1783) and Kellie (1824), which states, once the
fontanelles and sutures are closed, that (i) the brain is
enclosed in a non-expandable case of bone; (ii) the brain
parenchyma is nearly incompressible; (iii) the volume of the
blood in the cranial cavity is therefore nearly constant; and
(iv) a continuous outflow of venous blood from the cranial
cavity is required to make room for continuous incoming
arterial blood.5
The relationship between ICP and intracranial volume is
described by the non-linear pressure–volume curve
(Fig. 1).62 Classically, three parts of the intracranial
pressure–volume curve are described:62 a flat part at lower
intracerebral volumes, where good compensatory reserve is
found, that is ICP remains low and stable despite changes in
intracranial volume. This is attributable to compensatory
mechanisms, that is the reduction of the volume of cere-
brospinal fluid (CSF) or intracranial blood. Once these
mechanisms are exhausted, the curve rapidly turns upwards,
acquiring an exponentially rising shape. This part of the
curve represents low compensatory reserve, that is ICP
increases considerably even with relatively small increases
in intracerebral volume. Finally, at high levels of ICP, the
curve plateaus again, denoting terminal disturbance in
cerebrovascular responses, when cerebral perfusion pres-
sure (CPP) is very low and ICP equals mean arterial pressure
(MAP). The cerebral arterial bed cannot dilate any more and
starts to collapse because of the further increase in brain
tissue pressure. Therefore, the system ‘gains’ some extra
buffering capacity previously occupied by arterial blood
volume. This third part of the pressure–volume curve has
been confirmed experimentally46 62 and also observed
clinically, although only indirectly.30 84
Raised ICP is a common problem in neurosurgical and
neurological patients. Frequent causes are intracranial mass
lesions, disorders of CSF circulation, or more diffuse patho-
logical processes. The gold standard for assessing ICP is an
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intraventricular drain inserted into one of the lateral vent-
ricles and connected to an external pressure transducer.1 The
foramen of Monro or for clinical purposes the external aud-
itory meatus is the reference point for zeroing a transducer
and repetitive zeroing may be performed after insertion of
the catheter. In addition to monitoring pressure, these cath-
eters allow withdrawal of CSF to treat raised ICP. The main
limitation of this method is the risk of infection that
increases over time and is in the range 6–11%.9 68 The
insertion of ventricular catheters may be difficult in patients
with severe brain swelling. The best alternative to the vent-
ricular catheter are intraparenchymal probes.21 These
devices either use a miniature strain gauge pressure sensor
mounted at the tip of a thin catheter, or a fibreoptic catheter.
With the former system a change of ICP results in a change
in resistance and in the latter a change of ICP results in a
change in reflection of the light beam. The main limitation
of intraparenchymal probes is a small drift of the zero ref-
erence.1 In vitro testing of modern probes has found drift as
low as 0.6 (0.9) mm Hg (SD) after 5 days of testing.22
Recalibration can generally not be performed once the sen-
sor has been inserted. The infection rate of intraparenchymal
probes is very low. Alternatively, subarachnoid, subdural
and epidural devices can be used (Fig. 2). However, the
accuracy of these devices is lower than that of intraventricu-
lar or intraparenchymal sensors.16 Pressure measured in the
lumbar CSF space is not a reliable estimator of ICP in
brain-injured patients,6 and such measurements may be
dangerous in patients with space occupying lesions.
When it is not possible to insert an ICP monitoring device,
for example because of severe coagulopathy, it is possible to
estimate ICP from a transcranial Doppler examination with
an absolute accuracy in the range ±10–15 mm Hg in most
cases (Table 1).2 31 Techniques using tympanic membrane
displacement to measure ICP have been unsatisfactory so
far90 but, ultrasound wave transmission has shown some
promise.
Normal ICP depends on age and body posture. Normal
ICP in a supine healthy adult ranges between 7 and 15 mm Hg.
In the vertical position it is negative with an approximate
mean of 10 mm Hg but not exceeding 15 mm Hg.32 In
term infants 1.5–6 mm Hg are considered normal, whereas in
children values between 3 and 7 mm Hg are quoted.39
ICP cannot be assumed to be evenly distributed in many
pathological states and it is important to realize that even with
a ventricular catheter, uniformly distributed ICP will only be
observed when CSF circulates freely between all its natural
pools. An intraparenchymal probe measures local pressure
that can be compartmentalized and is not necessarily identical
with intraventricular pressure. Significant pressure gradients
may exist in patients with intracranial hypertension. For
example supratentorial measurements do not necessarily
reflect infratentorial pressure86 and bilateral ICP monitoring
has demonstrated large ICP gradients in patients with expand-
ing mass lesions,17 subdural haematomas,18 or even in
absence of space occupying lesions.73
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Fig 1 Intracranial pressure–volume curve. Illustration of the intracranial pressure–volume curve and the relationship between pulsating changes in
CBV and the ICP waveform. Index: index of cerebrospinal compensatory reserve calculated as the moving correlation coefficient between the
amplitude of the fundamental harmonic of the ICP pulse wave and mean ICP. Steiner and colleagues,96 reprinted with permission of the publisher.
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Fig 2 ICP monitoring. (A) Possible sites of ICP monitoring: a: intraventricular drain; b: intraparenchymal probe; c: epidural probe; d: subarachnoid
probe. (B) Typical system for ICP measurement via an intraventricular drain: a: connection with drain; b: zero (should be positioned at height of
patient’s ear) and three-way stopcock for connection with pressure transducer; c: drip chamber, adjustable in height over zero for CSF drainage.
Depending on stopcock position (b) either pressure measurements or CSF drainage are possible; and d: CSF reservoir. (C) Possible configuration for
intraparenchymal probe. Pressure is sensed at the tip of the probe by a miniature sensor consisting of piezo-elements or other pressure sensitive
elements arranged as a Wheatstone bridge.
Table 1 Characteristics of different methods for ICP monitoring. ICP, intracranial pressure; CSF, cerebrospinal fluid
Method Advantages Disadvantages
Intraventricular catheter ‘Gold standard’
Allows drainage of CSF to lower ICP
Re-zeroing possible
Most invasive method
High infection rate
May be difficult to insert
Simultaneous CSF drainage and
ICP monitoring not possible
Intraparenchymal probe Low infection rate Measures local pressure
Drift of zero over time
Subarachnoid probe Low infection rate
No brain penetration
Limited accuracy
High failure rate
Periodic flushing necessary
Epidural probe Low infection rate
Easy to insert
No penetration of dura
Limited accuracy
Relatively delicate
Lumbar CSF pressure Extracranial procedure Inaccurate reflection of ICP
May be dangerous when brain
oedema is present
Tympanic membrane displacement Non-invasive Insufficient precision
Transcranial Doppler Non-invasive Limited precision
Fig 3 Examples of ICP monitoring. (A) Low and stable ICP. Mean arterial blood pressure (ABP) is plotted along the lower panel. (B) Stable and
elevated ICP—this can be seen most of the time in head-injury patients. (C) ‘B’ waves of ICP. They are seen both in mean ICP and spectrally
resolved pulse amplitude of ICP (AMP, upper panel). They are also usually seen in plots of time averaged ABP, but not always. (D) Plateau waves
of ICP. Cerebrospinal compensatory reserve is usually low when these waves are recorded [RAP: correlation coefficient (R) between AMP
amplitude (A) and mean pressure (P)] close to +1; index of compensatory reserve. At the height of the waves, during maximal vasodilatation,
integration between pulse amplitude and mean ICP fails as is indicated by a decrease in RAP. After the plateau wave, ICP usually decreases below
baseline level and cerebrospinal compensatory reserve improves. (E) High, spiky waves of ICP caused by sudden increases in ABP. (F) Increase in
ICP caused by temporary decrease in ABP. (G) Increase in ICP of ‘hyperaemic nature’. Both blood flow velocity and jugular venous oxygen
saturation (SjO2) increased in parallel with ICP. (H) Refractory intracranial hypertension. ICP increased within a few hours to above 100 mm Hg.
The vertical line denotes the moment when the ischaemic wave probably reached the vasomotor centres in the brain stem: heart rate increased and
ABP (CPP) decreased abruptly. Note that the pulse amplitude of ICP (AMP) disappeared around 10 min before this terminal event. Czosnyka and
Pickard,32 reprinted with permission from the BMJ Publishing Group.
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Why is it important
In contrast to most other organs the brain is protected by a
stiff skull. An increase in ICP may therefore impede cerebral
blood flow (CBF) and cause ischaemia. Raised ICP is an
important secondary insult in brain-injured patients and a
predictor of poor outcome after traumatic brain injury. It is
used as a target in many treatment algorithms. ICP is also
used to calculate CPP, which is the difference between MAP
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and ICP (CPP=MAPICP). CPP represents the pressure
gradient across the cerebral vascular bed and is used as a
therapeutic target for brain-injured patients in many inten-
sive care units and is recommended by the Brain Trauma
Foundation’s, evidence based guideline.1
Clinical role
Indications for ICP monitoring vary from unit to unit
and may include severe head injury, intracerebral and
subarachnoid haemorrhage, hydrocephalus, or brain oedema
after large strokes, hypoxic brain injury, central nervous sys-
tem infections, or fulminant hepatic failure. ICP thresholds,
above which therapy is started, depend on age and disease.
In hydrocephalus values greater than 15 mm Hg are
regarded as elevated,32 whereas in head-injured adults the
ICP threshold, above which outcome will be affected neg-
atively, is between 20 and 25 mm Hg.1 Above 25 mm Hg,
aggressive treatment is started in most intensive care units.
There is controversy concerning critical thresholds for ICP in
children. Recently, it has been suggested that ICP should be
treated above a threshold of 15 mm Hg in infants, 18 mm Hg
in children younger than 8 yr and 20 mm Hg in older children
and teenagers.69 However, it is important to realize that there
has never been a randomized controlled trial showing an
outcome benefit for patients with ICP monitoring when com-
pared with patients without ICP monitoring. Indeed a recent
observational study has suggested that a CPP/ICP oriented
therapy will increase treatment intensity and respirator days
without an improvement in outcome.28 It should be noted,
that the non-monitored group had intensive cross-sectional
imaging and motor score assessment (GCS) in lieu of ICP
monitoring.
When CPP is used as a target for therapy there is further
controversy as to which thresholds should be used. The
Lund protocol suggests a lower limit of 50 mm Hg;7 the
revised guidelines of the Brain Trauma Foundation suggest
60 mm Hg1 and earlier work suggested that in individual
patients a CPP of 80 mm Hg or more may be required.88
There have been some attempts to identify individual thresh-
olds for CPP management. Methods such as transcranial
Doppler and jugular bulb oxymetry,19 microdialysis,75
brain tissue oxymetry,70 and an index of pressure reactiv-
ity99 have been used for this purpose. So far there is no
evidence that such an approach improves outcome. More
recently it has also been shown that inappropriately high
CPP is associated with poor outcome.10 41 Again there is
controversy whether the upper limit should be set at 60,41
70,1 or 90 mm Hg.10
The rationale of any CPP augmentation is to increase
CBF in brain regions which have critically low blood
flow. However, an increase in CPP will only lead to an
increase in CBF when autoregulation has failed or CPP is
below the lower limit of autoregulation.66 In a normal brain
CBF is constant in the CPP range of about 50–150 mm Hg
because of autoregulation80 and a shift to the right of the
autoregulation curve has been suggested after brain injury.
Autoregulation is frequently disturbed in brain inured
patients;36 37 47 94 nevertheless, the effects of CPP augmen-
tation are difficult to predict and may be small despite large
increases in CPP.25 98
When ICP is monitored and recorded continuously typical
patterns emerge (Fig. 3). Many patients have relatively
stable ICP below or above 20 mm Hg. The term refractory
intracranial hypertension is used when ICP increases over a
few hours to very high values and leads to the death of the
patient unless aggressive measures such as craniectomy are
instituted. In some patients, spontaneous ICP waves are
observed. Waves can be analysed in the time domain
according to the classification proposed by Lundberg in
1960:63 ‘A’ waves or plateau waves comprise a steep
increase in ICP from near normal values to 40 or more
mm Hg persisting for 5–20 min. Plateau waves are always
pathological and occur in patients with intact autoregulation
and reduced intracranial compliance.87 ‘B’ waves are ICP
oscillations that occur at 0.5–2 waves min1. ICP can
increase to 20 mm Hg above baseline. These waves are
probably related to changes in vascular tone, as transcranial
Doppler typically shows increases of blood flow velocity in
the middle cerebral artery at the same frequency as the ‘B’
waves. Lundberg also described ‘C’ waves as oscillations
that occur with a frequency of 4–8 min1. These waves are
probably of little pathological significance. ICP changes can
also be the result of changes in CBF or arterial pressure,
especially when intracranial compliance is reduced. Any
change in cerebral blood volume (CBV) will lead to an
increase in ICP. Such changes may be caused by intracranial
events, for example seizures, or in response to a change in
systemic variables such as, MAP, temperature, blood gases,
serum sodium and inflation pressures. It is also worth noting
that compliance decreases with age and may account for
some of the poor outcome in elderly brain-injury patients.55
In chronic disease such as hydrocephalus or benign intra-
cranial hypertension, ICP needs to be interpreted somewhat
differently. In hydrocephalus CSF circulation and assess-
ment of pressure volume compensation are important. Over-
night ICP monitoring and tests where volume is added to the
CSF space are important, especially in patients who present
with persisting or recurring symptoms after insertion of a
shunt.51
Use in research settings
The response of ICP to changes in MAP depends on the
pressure reactivity of the cerebral blood vessels. Pressure
reactivity is defined as the vascular response to a change in
transmural pressure and is a key component of pressure
autoregulation. Disturbed pressure reactivity implies dis-
turbed pressure autoregulation. If pressure reactivity is
intact, an increase in MAP will lead to a cerebral vasocon-
striction within 5–15 s with reductions of both CBV and
ICP. If pressure reactivity is impaired, CBV will increase
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passively with increasing MAP, and ICP will increase.
Opposite effects will occur when MAP is reduced. Dis-
turbed pressure reactivity is associated with poor outcome
after head injury. Using the relationship between MAP and
ICP pressure reactivity can be monitored continuously.33
Recent results suggest that pressure reactivity may influence
the choice of a treatment strategy in head-injured patients48
or may be used to define individual CPP targets.99
The ICP waveform consists typically of three components
which overlap in the time domain but may be separated by
analysis in the frequency domain. The pulse waveform has
several harmonics, the fundamental of which corresponds to
the frequency of the heart rate. The second component is
attributable to the frequency of the respiratory cycle and the
third component consists of ‘slow waves’ which are within
the frequency limits of 0.05–0.0055 Hz. This definition of
slow waves is less precise as the one used by Lundberg.
Recently, the power of these slow waves has been shown to
predict the outcome of patients with raised ICP after trau-
matic brain injury. A low content of slow waves in the
overall ICP dynamics was associated with death.11
It is possible to obtain information of an individual
patient’s position on his or her pressure–volume curve
from ICP monitoring data. The three parts of the pressure–
volume curve can be identified by determining cerebrospinal
compensatory reserve using an index, calculated as the mov-
ing correlation coefficient between the amplitude of the fun-
damental harmonic of the ICP pulse wave and mean ICP.30
The principle on which this index is based is illustrated in
Figure 1. Possible values of this index range from 1 to +1
and it makes use of the fact that the amplitude of the ICP
waveform increases with mean ICP, at first slowly and, as
compensatory reserve decreases, more rapidly. In the flat
part of the pressure–volume curve the index equals approx-
imately zero. In the exponentially rising part of the curve the
value increases and eventually reaches a value of 1. With
very high ICP values (greater than 40 mm Hg), in the third
part of the curve, the index will become negative and
approach1.30 Earlier work showed that this index indicates
loss of further vasodilatatory capacity on top of plateau
waves35 and it was demonstrated that the combination of
a high ICP (>20 mm Hg) and a value for the index (<0.5)
was associated with poor outcome.30 A patient’s position on
the pressure–volume curve could be used to predict the risk of
deterioration or herniation. In a preliminary study, this index
was used to predict the response of ICP to hyperventilation.96
Alternatively, methods such as the Spiegelberg Brain Com-
pliance monitor have been developed to measure brain com-
pliance. The role of this new device is still under
investigation110 but offers the possibility of an early warning
system before decompensation.
Wider applicability
Raised ICP is an important feature of fulminant hepatic
failure and associated with a high mortality. Most likely
it is a consequence of cytotoxic oedema.81 Placement of
intraparenchymal ICP monitors in these patients has been
shown to lead to complications in 20% and fatal haemor-
rhage in up to 4% of patients.12 Epidural transducers may be
the safest choice for ICP monitoring in such patients, even
though they are known to be less precise than the other
devices. Treatment strategies of raised ICP in the context
of fulminant hepatic failure are still controversial.58
In summary, ICP is a complex parameter which contains
information about cerebral compensatory mechanisms and
mechanisms contributing to CBF regulation. ICP control
requires continuous ICP monitoring and integration of the
additional information in the ICP waveform and their
relationship to MAP to help us understand the underlying
pathophysiology.
Cerebral blood flow
What are we monitoring and how does it work
Bedside monitors for CBF can be characterized as quanti-
tative or qualitative monitors. Kety and Schmidt54 published
the first method for quantitative determination of global
CBF in patients in 1945. They used N2O as an inert tracer
gas and calculated CBF from the arterio–venous difference
of the N2O concentration based on a non-steady state
application of Fick’s principle. The method is still used
today with some modifications,108 and new methods of
measurement are often compared against it. Recently two
groups have proposed new techniques for quantitative deter-
mination of global CBF at the bedside. One is continuous
jugular thermodilution,71 the other a double-indicator
method based on injections of dye and iced water providing
non-continuous measurements.109 Both methods have not
yet gained widespread recognition and their usefulness is
currently being evaluated.52 The above methods are prone to
be problematic because of anatomical factors: methods that
rely on blood sampling from one of the jugular bulbs can be
influenced by the asymmetry of venous drainage. This may
introduce the unpredictable risk of acquiring misleading
data.59 72 101 A modification of the Kety–Schmidt technique
is the 133xenon method. 133Xenon is a g emitting freely
diffusible inert gas that interferes only moderately with
cerebral metabolism and is eliminated rapidly and almost
completely via the lungs. Application is possible by injec-
tion into the carotid artery or i.v.,4 or by inhalation.77 Quan-
titative CBF data are calculated based on washout curves.
Several detectors can be placed over each hemisphere and a
certain amount of information on regional perfusion can be
acquired although without precise anatomical correlation.
Accordingly, comparisons of the same region from one
study to another are difficult. Moreover, this method meas-
ures mainly cortical and subcortical blood flow within the
territory of the middle cerebral artery. Low flow can be
missed because of under or overlying adequate flow
(‘look-through phenomenon’).107 The equipment is bulky
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and patients are exposed to ionizing radiation. Interpretation
of both CBF and oxygen extraction fraction (OEF) require
knowledge of arterial blood pressure and more importantly
arterial Paco2. Correction of CBF and OEF should be made to
normocapnia as modest reductions in Paco2will increase
cerebral vascular resistance, OEF and reduce CBF. Large
regions of increased OEF may be iatrogenic, and while
important and of interest, they do not indicate a primary
ischaemia problem.
Thermal diffusion92 monitors focal cortical blood flow. A
probe is inserted through a burr hole and placed on a cortical
region of interest. The probe typically consists of two small
gold plates, one of which is heated. Local cortical blood flow
is calculated from the temperature difference between the
two plates, which decreases with rising blood flow. The
main advantage of this method is that the measurements
are continuous but only local information is obtained.
Recently, a modification of this technique using an intra-
parenchymal probe incorporating thermistors has been
evaluated in brain-injured patients.106 It provides continu-
ous quantitative real-time data that are in good agreement
with values obtained by Xenon-CT for a volume of approx-
imately 5 cm3 around the tip of the probe. This new tech-
nology seems to be promising because of its excellent
temporal resolution and potential to monitor a large part
of a vascular territory with one probe or several vascular
territories with multiple probes.
Jugular oximetry and transcranial Doppler provide non-
quantitative or ‘adequacy of CBF’ data and are the meth-
ods which are used most often in intensive care. Jugular
oximetry cannot directly measure CBF. Jugular bulb sat-
uration (SjO2) or the arterio-jugular oxygen content differ-
ence (AJDO2), which is calculated as the difference
between the arterial and jugular oxygen content in paired
blood samples, provide information about the adequacy of
global CBF in relation to metabolic demands (Figs 4
and 5). However, this is only correct if the cerebral meta-
bolic rate for oxygen (CMRO2) does not change independ-
ently of CBF, that is coupling between flow and
metabolism is intact. The placement of catheters in the
jugular bulb allows sampling of blood that almost exclus-
ively drains from the intracranial circulation. Despite the
fact that blood is usually sampled from one jugular bulb
only, it is assumed that the values relate to global CBF
rather than hemispherical CBF. However, typically only
two-thirds of the sampled blood are drained from the ipsi-
lateral hemisphere40 and there is a large inter-individual
variability of venous drainage of the brain which explains
why methods relying on blood sampling from one of the
jugular bulbs are prone to the influence of asymmetry of
cerebral venous drainage.72 101 It is impossible to predict
which side in a specific patient will give more important
data,101 and there is no consensus on which side should be
cannulated. Generally, the right internal jugular vein is
preferred because it often is the dominant vessel. Altern-
atively, the side with the larger jugular foramen can be
used or the side on which a compression of the jugular
vein causes a greater increase in ICP. The catheter tip
should lie at the level of the first or second cervical ver-
tebral body, that is above the point at which the jugular
vein receives its first extracranial tributary, the facial vein,
The extracranial contamination at this level is considered
to be about 3%.40 The correct position of the catheter
should be confirmed with a lateral cervical spine X-ray.
Blood can be sampled intermittently or a fibreoptic cath-
eter can be used to continuously determine SjO2. If samples
are withdrawn too quickly falsely elevated values may be
found because of retrograde aspiration of extracranial
blood. A rate of blood withdrawal of less than 2 ml min1
should be used.67 Fibreoptic catheters need to be recal-
ibrated at regular intervals and are susceptible to artifacts
as a result of the catheter position inside the vessel. It has
been shown that when a fibreoptic catheter is used for
continuous SjO2 monitoring ‘time of good quality data’
can be as low as 43% of the monitoring time.56
Normal values for AJDO2 range from 4 to 9 ml 100 ml
1.42
Low CBF and ischaemia raise oxygen extraction and
increase AJDO2, whereas hyperaemia will lead to a decrease
in AJDO2. If CMRO2 remains constant between measure-
ments, changes in CBF can be estimated using the following
relationship:
CBF=
CMRO2
AJDO2
and CBF 1
AJDO2
:
In view of the anatomical limitations it is not surprising
that the estimates of changes in global CBF are not very
accurate in head-injured patients with this method.97 Jugular
bulb oximetry is a global monitor and its sensitivity to detect
regional ischaemia is small. A recent study in head-injured
patients using positron emission tomography (PET) to
quantify the ischaemic brain volume found that 170 (63)
ml of brain volume were ischaemic at an SjO2 of 50%,
24
although the PET definition requires refining and lacks
correction for Paco2.
Transcranial Doppler was introduced to clinical practice
in 1981.3 It is based on the Doppler principle,38 easy to use
and non-invasive, and can be used repeatedly. Transcranial
Doppler measures blood flow velocity in the basal cerebral
arteries not CBF, and the linear relationship between CBF
and mean flow velocity (CBF=mean flow velocity·area of
the insonated vessel·cosine of the angle of insonation) is
only present if neither the diameter of the insonated vessel,
nor the angle of insonation change during the examination.
This assumption is probably fulfilled for most situations
where examinations of the basal cerebral arteries are per-
formed44 49 89 with the possible exception of cases of sub-
arachnoid haemorrhage leading to vasospasm. Examination
of the ratio of extracranial internal carotid blood flow velo-
city to middle cerebral artery blood flow velocity helps
differentiate vasospasm from increased CBF (Lindegaard
Index).61 Reasonable correlations have been reported
between transcranial Doppler and xenon computed
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tomography and PET CBF measurements.15 97 As a tool for
the rapid estimation of CBF over a wide range of flows with
the potential to detect vasospasm, transcranial Doppler is the
simplest way to non-invasively obtain repeated real-time
estimates of CBF (Fig. 6).
Why is it important?
Autopsy data have repeatedly shown that brain ischaemia is
common in non-survivors of traumatic head injury and it is
likely that inadequate CBF significantly contributes to the
occurrence of post-traumatic secondary brain insults and
therefore increases the probability of a poor outcome
after brain injury.13 50 79 83 CBF thresholds for ischaemia
have initially been established in baboons by the group of
Symon and colleagues103 at 15 ml 100 g1 min1. The
same group has also introduced the concept of the penum-
bra, defined as a zone of brain where because of inadequate
perfusion neuronal function is lost but can be recovered
when adequate perfusion is restored.8 14 Using PET in
humans suffering from ischaemic stroke the threshold for
infarction was established at a CBF of 8 ml 100 g1 min1
and that for the penumbra at 20 ml 100 g1 min1, that is the
tissue with a CBF between these two thresholds is
potentially salvageable but will proceed to infarction if
CBF is not restored within a limited time window.43 64
Therefore, CBF or adequacy of CBF monitoring offers a
rational approach to detect and prevent secondary insults
and improve the outcome of these patients. The situation is
less clear with high CBF (absolute or relative) as both bene-
ficial and detrimental effects are possible and the relation-
ship between elevated CBF and ICP is still unclear.53
Clinical role
Techniques to alter CBF are double-edged ‘scalpels’ and
reliable and reproducible effects vary between and within
patients when effects are assessed regionally and globally.98
Even if we were able to adjust CBF to a certain target value,
it would still be unclear what the appropriate value should
be. The metabolic demands of the brain influence the thresh-
olds for ischaemia and hyperaemia and our therapeutic inter-
ventions such as sedation or hypothermia will change these
thresholds in an unpredictable manner. It is therefore not
possible to use the absolute CBF thresholds for ischaemia
cited above. Because of the shortcomings of technology,
qualitative CBF trend monitoring rather than quantitative
measurements of CBF is the clinical reality.
AJDO2: 10%
CMRO2: 3 ml 100 g–1 min–1
SJO2: 75%
SJO2: 50%
AJDO2: 5%
SaO2: 100%
SaO2: 100%
Global CBF 60 ml 100 g–1 min–1
Global CBF 30 ml 100 g–1 min–1
Facial vein
Jugular bulb
Catheter
C2
A
B
Internal jugular vein
Fig 4 Jugular bulb oximetry. (A) Catheter inserted into the internal jugular vein. The tip of the catheter must lie in the jugular bulb or at or above
the level of the body of the 2nd cervical vertebra (C2). Blood can be sampled intermittently or oxygen saturation can be measured continuously
using a fibreoptic catheter. The facial vein is the first large extracranial vein draining into the internal jugular vein. Rapid aspiration of blood
samples (>2 ml min1) will result in extracranial contamination of samples. Jugular bulb catheters should be flushed continuously with normal saline
(2 ml h1). Thrombosis of the internal jugular vein is a possible complication which may result in raised ICP. (B) Principle of SjO2 monitoring.
Sao2, arterial oxygen saturation; CMRO2, cerebral metabolic rate for oxygen; CBF, cerebral blood flow; AJDO2, arterio-jugular difference in oxygen
content; SjO2, jugular venous oxygen saturation. CMRO2 is identical in the upper and lower half of figure. Upper panel: adequate CBF, normal
AJDO2 and SjO2. Lower panel: inadequate CBF, increased AJDO2 and low SjO2.
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Despite the many limitations of the method, interest has
focused on SjO2 monitoring. In head-injured patients it has
been shown that repetitive reductions of SjO2,
45 and high
values27 are associated with poor outcome. There are only
two studies29 85 that compare a CBF-targeted treatment
strategy with another approach and both used SjO2, as a
qualitative monitor with good temporal resolution, to esti-
mate adequacy of CBF. The first study,85 a randomized
trial, was designed to answer the question, whether a
CBF-targeted protocol, using a higher arterial blood pres-
sure and optimized volume management to augment CBF,
without targeting a specific range of CBF and or SjO2, was
superior to a conventional ICP-based strategy. It failed to
demonstrate a difference in outcome for these two strat-
egies. The main limitation of this study is that in the ICP-
based strategy group episodes of low SjO2 were treated in
the same way as in the CBF group. However, despite not
finding a difference in outcome, the authors concluded
that a CBF-targeted management protocol could prevent
secondary injury because the CBF-targeted protocol
reduced the frequency of jugular desaturations, and there-
fore the risk of cerebral ischaemia significantly. This study
reported one unexpected observation: 15% of patients in the
treatment group developed an adult respiratory distress syn-
drome (ARDS). While this percentage is well within the
reported incidence in trauma patients, it was nevertheless
surprising that the rate was almost five times that of the
control group. The data were later reanalysed to assess
whether ARDS is a complication of induced hypertension.
Using a logistic regression model, administration of ephed-
rine, administration of larger doses of dopamine (median
dose in patients without ARDS: 35 mg kg1 24 h1, in
patients with ARDS: 215 mg kg1 24 h1), and a history
of drug abuse were found to be associated with an increased
risk to develop ARDS.26 It is therefore likely that the bene-
ficial effects of the CBF-targeted management were par-
tially offset by the morbidity and mortality associated
with ARDS. The second study,29 providing class II
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Fig 5 Adequacy of CBF monitoring: clinical examples of jugular bulb oximetry. MAP, mean arterial pressure; ICP, intracranial pressure; SjO2,
jugular bulb oxygen saturation. (A) Change in SjO2 with increases in ICP. (B) Change in SjO2 with low CPP (=MAPICP).
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evidence, compared a CBF-targeted approach using manip-
ulation of Paco2, that is ‘optimized hyperventilation’, to
maintain cerebral oxygen extraction at 24–42%, based on
the AJDO2, to a management based on maintaining CPP
above 60 mm Hg. This study found that the outcome was
better with the optimized hyperventilation protocol. How-
ever, there are several issues, such as the choice of the CPP
threshold in the control group and the use of vasodilators,
that prevent this publication from serving as a strong argu-
ment that control of CBF by optimized hyperventilation is
clearly superior to a CPP-targeted management.20
Transcranial Doppler is used frequently for the detection
and monitoring of vasospasm in patients after aneurysmal
subarachnoid haemorrhage. Reasonable sensitivity and spe-
cificity are reported especially for the middle cerebral artery
and the basilar artery, however, it is currently unknown
whether monitoring of vasospasm with transcranial Doppler
has an impact on outcome.93
Use in research settings
Monitoring of CBF also gives us the possibility to assess the
reactivity of the cerebrovascular bed to changes in CPP,
arterial partial pressure of CO2 (Paco2) or brain metabolism.
For the assessment of vascular reactivity, mostly transcra-
nial Doppler is used to measure changes in CBF velocity.
While assessment of CO2-reactivity has its place in the
assessment of patients with stenotic carotid artery disease,
the response of CBF velocity to stimuli such as changes in
MAP, arterial partial pressure of CO2, or metabolic suppres-
sion are used primarily in research. Intact autoregulation
has been shown to be a powerful protective mechanism
for the injured brain as it is associated with good
outcome33 34 36 57 78 and several methods for determination
of the autoregulatory status are available. Most methods
measure the CBF response to a single reduction in MAP
or CPP. A distinction is made between dynamic measure-
ments evaluating changes within the first seconds after the
stimulus and steady-state measurements. However, there is a
good correlation between these two types of measure-
ment.104 105 More sophisticated methods evaluate the
phase shift, correlation or spectral coherence between
changes in CBF and CPP34 100 or fit various dynamic models
to transcranial Doppler blood flow velocity and arterial
blood pressure data.91 These methods generally give non-
continuous information. Continuous monitoring of auto-
regulation is also possible using methods that calculate
an index of autoregulation34 based on the response of
flow velocity to slow spontaneous changes in CPP. After
trauma, reactivity to changes in Paco2 seems to be less vul-
nerable than autoregulation as intact CO2 reactivity is fre-
quently found in the presence of disturbed autoregulation, a
phenomenon called ‘dissociated vasoparalysis’.23 Loss of
reactivity to changes in Paco2 is associated with poor out-
come.65 76 Also, the response of flow velocity to metabolic
suppression for instance by using propofol titrated to
achieve burst suppression can be measured.60 Finally, non-
invasive estimation of ICP and CPP is an area of interest and
transcranial Doppler has been used to achieve this.2 31
Wider applicability
Postoperative neurological complications are frequently
found in patients undergoing cardiac surgery. Cerebral
infarction and encephalopathy have been reported in 15%
of patients who undergo coronary-artery bypass grafting82
and more than 50% of such patients may have postoperative
cognitive deficits.74 The aetiology of these complications is
still not completely understood and jugular oximetry,95 and
transcranial Doppler102 have been used in this context.
Conclusion
Current management strategies for acute brain injury
patients encompass the principle of physiological stability.
Although there is debate about which precise thresholds
should be striven for, without monitoring ICP, considerable
information is missing and objective management of the
Doppler probe (2MHz)
Middle cerebral artery
A
B
C
Fig 6 Transcranial Doppler. (A) Typical transcranial Doppler machine. (B) Illustration of insonation of middle cerebral artery through temporal bone.
(C) Typical printout of signal from the middle cerebral artery. y-axis, blood flow velocity in cm s1.
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patient not possible. Interventions to reduce ICP are double-
edged swords and direct measurement will reduce their
indiscriminate usage. ICP monitors are inexpensive and
have an acceptably low complication rate. They offer a
high yield in information and should be the cornerstone
of all critical care management of acute brain injury. The
role of CBF monitoring is less clear. Currently, SjO2
and transcranial Doppler are the methods that are used
most frequently. However, there is no clear evidence that
incorporating data from these methods into our management
strategies improves the outcome in brain-injured patients.
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